Skip to Main Content

Author Details

Michelle Haber
School of Clinical Medicine
1973
242
54
PMIDPaper TitleJournal TitlePublished Year
36346110Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastoma.Int J Cancer2023
37958555Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma.Int J Mol Sci2023
37523146High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer.Cancer Res2023
37511646Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial.J Pers Med2023
37726477Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives.Br J Cancer2023
37013636A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.Genome Med2023
37196067Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.Sci Transl Med2023
36656928Heritable defects in telomere and mitotic function selectively predispose to sarcomas.Science2023
36882456Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes.Sci Rep2023
36867694Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma.Sci Adv2023
34807782Methodological advances in the discovery of novel neuroblastoma therapeutics.Expert Opin Drug Discov2022
35677155The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression.Front Oncol2022
35365224Donor T cells for CAR T cell therapy.Biomark Res2022
35454786Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer.Cancers (Basel)2022
36449545Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors.Proc Natl Acad Sci U S A2022
35127484Systematic <i>In Vitro</i> Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia.Front Oncol2022
35080351GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulators.FEBS J2022
34471258Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.Br J Cancer2022
33310889Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.Clin Cancer Res2021
33852836Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.Cell Rep2021
33712556Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.Cell Death Dis2021
33895784Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia.Leukemia2021
33918978A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma.Cancers (Basel)2021
33837299Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.Br J Cancer2021
33658627A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma.Oncogene2021
33579942Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.Nat Commun2021
33497018The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma.Mol Oncol2021
34983733Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition.Drug Resist Updat2021
34944614Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors.Biomedicines2021
34375680Early-phenotype CAR-T cells for the treatment of pediatric cancers.Ann Oncol2021
34572932Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma.Cancers (Basel)2021
34826366A Primer for Assessing the Pathology in Mouse Models of Neuroblastoma.Curr Protoc2021
33994371Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.Clin Cancer Res2021
34019301Cell-Based Methods for the Identification of Myc-Inhibitory Small Molecules.Methods Mol Biol2021
34183305Immunometabolism: A 'Hot' Switch for 'Cold' Pediatric Solid Tumors.Trends Cancer2021
33954150Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy.Immunotargets Ther2021
31325323Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.Int J Cancer2020
31876116Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia.Pediatr Blood Cancer2020
31896781OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis.Leukemia2020
31862449CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.Biochem Pharmacol2020
31919402Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.Br J Cancer2020
31848452Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia.Leukemia2020
33144287Recurrent <i>SPECC1L-NTRK</i> fusions in pediatric sarcoma and brain tumors.Cold Spring Harb Mol Case Stud2020
33139218Corrigendum to: "MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma" [Biochim. Biophys. Acta, Gene Regul. Mech. 1861 (2018) 235-245].Biochim Biophys Acta Gene Regul Mech2020
33049203Advances and Challenges in Pediatric and Childhood Cancers.Cancer Cell2020
32801162Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in <i>CRLF2</i>-Rearranged Ph-like ALL.Mol Cancer Res2020
32651259Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer Progression.Cancer Res2020
32816860Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion.Cancer Res2020
32123312Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.Oncogene2020
32277480ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.Int J Cancer2020
  • 1 - 50 of 242

Recommended Authors

Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 22
Jun S Wei
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 29
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 0
Andr?? S Bachmann
College of Human Medicine, Michigan State University
Career Start Year 1998
Number of shared co-authors 1
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Career Start Year 1996
Number of shared co-authors 13
Jaume Mora
Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu
Career Start Year 1996
Number of shared co-authors 20
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 26
Michael A Grotzer
University Children's Hospital
Career Start Year 1994
Number of shared co-authors 16
Bill H Chang
Oregon Health and Science University
Career Start Year 1993
Number of shared co-authors 2
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1993
Number of shared co-authors 25
Ute Fischer
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 4
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 19
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1989
Number of shared co-authors 15
Dirk Geerts
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 2
Poul H Sorensen
British Columbia Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 22
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 8
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 7
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 4
James M Olson
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 1985
Number of shared co-authors 16
Anna Lasorella
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Career Start Year 1984
Number of shared co-authors 4
William C Reinhold
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 5
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 27
Robert H Shoemaker
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 0
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 5
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Career Start Year 1977
Number of shared co-authors 3
Alex Look
Dana-Farber Cancer Institute
Career Start Year 1975
Number of shared co-authors 14
Timothy J Triche
Center for Epigenetics, Van Andel Research Institute
Career Start Year 1971
Number of shared co-authors 18
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 37

Collaborators

Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 123
Michelle J Henderson
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 34
Jamie I Fletcher
Co-authored papers 29
Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 29
David S Ziegler
Co-authored papers 24
Richard B Lock
Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine
Co-authored papers 20
Susan L Cohn
Co-authored papers 14
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers 11
Paul G Ekert
Co-authored papers 11
Vanessa Tyrrell
Lowy Cancer Research Centre, Children's Cancer Institute
Co-authored papers 10
Anna DeFazio
Westmead Hospital
Co-authored papers 7
Matthias Fischer
University Children's Hospital of Cologne
Co-authored papers 7
Maria Tsoli
Co-authored papers 6
Michael D Hogarty
Co-authored papers 6
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 6
John M Maris
Children's Hospital of Philadelphia
Co-authored papers 5
André Oberthuer
Co-authored papers 5
William A Weiss
University of California san francisco
Co-authored papers 5
Gudrun Schleiermacher
Institut Curie
Co-authored papers 5
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers 4
Sharon E Johnatty
QIMR Berghofer Medical Research Institute
Co-authored papers 4
Peter F Ambros
Children's Cancer Research Institute, Medical University of Vienna
Co-authored papers 4
Marcel E Dinger
The University of Sydney
Co-authored papers 4
Bo Gao
Crown Princess Mary Cancer Centre, Westmead Hospital
Co-authored papers 4
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 4
Malcolm A Smith
National Cancer Institute
Co-authored papers 4
Jo Vandesompele
Co-authored papers 4
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Co-authored papers 4
Andreas du Bois
Co-authored papers 3
Rodney J Scott
Co-authored papers 3
Release 1.2